ABY-029
- Generic Name
- ABY-029
A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT03282461
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
A Microdose Evaluation Study of ABY-029 in Primary Sarcoma
- First Posted Date
- 2017-05-16
- Last Posted Date
- 2021-08-30
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT03154411
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
A Microdose Evaluation Study of ABY-029 in Recurrent Glioma
- First Posted Date
- 2016-09-15
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT02901925
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath